Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: A systematic review and meta-analysis of randomized trials

被引：0
|
作者：
Mauri, D. [1 ]
Filis, P. [1 ]
Markozannes, G. [2 ]
Filis, N. [3 ]
Tsilidis, K. [2 ]
机构：
[1] Univ Hosp Ioannina, Dept Med Oncol, Ioannina, Greece
[2] St Marys Hosp Imperial Coll Healthcare NHS Trust, Dept Epidemiol & Biostat, London, England
[3] UOI Univ Ioannina, Med Sch UOI, Ioannina, Greece
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.668
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
540P
引用
收藏
页码：S794 / S794
页数：1
相关论文
共 50 条
  • [21] Hyperthermic intraperitoneal chemotherapy (HIPEC) is cost-effective in the management of primary ovarian cancer
    Behbakht, Kian
    Cohn, David E.
    Straughn, J. Michael, Jr.
    GYNECOLOGIC ONCOLOGY, 2018, 151 (01) : 4 - 5
  • [22] Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Associated with Cytoreductive Surgery in the Treatment of Advanced Ovarian Cancer: Systematic Review and Meta-Analysis
    Llueca, Maria
    Ibanez, Maria Victoria
    Climent, Maria Teresa
    Serra, Anna
    Llueca, Antoni
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (02):
  • [23] Comparative Survival Outcomes of Hyperthermic Intraperitoneal Chemotherapy, Intraperitoneal Chemotherapy and Intravenous Chemotherapy for Primary Advanced Ovarian Cancer: A Network Meta-Analysis
    Tang, Qin
    Huang, Mao
    Zhang, Jing
    Huang, Zhen
    Wang, Linlian
    Gong, Zhengxin
    Tang, Liangdan
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (03)
  • [24] Hyperthermic Intraperitoneal Chemotherapy (HIPEC) as Primary Treatment of Ovarian Cancer: A Review of the Current Literature
    Zirak-Schmidt S.
    Verwaal V.J.
    Indian Journal of Gynecologic Oncology, 2018, 16 (3)
  • [25] Debate on hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced epithelial ovarian cancer
    Van Driel, Willemin
    Vergote, Ignace
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (04) : 454 - 455
  • [26] Citoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian cancer
    Aguiar, S.
    Ferreira, F. O.
    Barroso, A.
    Rossi, B. M.
    Nakagawa, W. T.
    Melo, C. A.
    Lopes, A.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 116 - 116
  • [27] The short- and long-term survival of hyperthermic intraperitoneal chemotherapy (HIPEC) in the advanced gastric cancer with/without peritoneal carcinomatosis: a systematic review and meta-analysis of randomized controlled trials
    Huachu Deng
    Baibei Li
    Xingan Qin
    Updates in Surgery, 2022, 74 : 1805 - 1816
  • [28] The short- and long-term survival of hyperthermic intraperitoneal chemotherapy (HIPEC) in the advanced gastric cancer with/without peritoneal carcinomatosis: a systematic review and meta-analysis of randomized controlled trials
    Deng, Huachu
    Li, Baibei
    Qin, Xingan
    UPDATES IN SURGERY, 2022, 74 (06) : 1805 - 1816
  • [29] Effects of CytoReductive surgery plus hyperthermic IntraPEritoneal chemotherapy (HIPEC) versus CytoReductive surgery for ovarian cancer patients: A systematic review and meta-analysis
    Wang, Yizi
    Ren, Fang
    Chen, Peng
    Liu, Shuang
    Song, Zixuan
    Ma, Xiaoxin
    EJSO, 2019, 45 (03): : 301 - 309
  • [30] Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: A meta-analysis
    Kim, Se Ik
    Kim, Ji Hyun
    Lee, Sanghee
    Cho, Hyunsoon
    van Driel, Willemien J.
    Sonke, Gabe S.
    Bristow, Robert E.
    Park, Sang-Yoon
    Fotopoulou, Christina
    Lim, Myong Cheol
    GYNECOLOGIC ONCOLOGY, 2022, 167 (03) : 547 - 556
12345